首页> 外文会议>Gums and Stabilisers Conference >GUM ARABIC ATTENUATES THE DEVELOPMENT OF NEPHROPATHY IN TYPE 1 DIABETES RAT
【24h】

GUM ARABIC ATTENUATES THE DEVELOPMENT OF NEPHROPATHY IN TYPE 1 DIABETES RAT

机译:阿拉伯语中的口香糖衰减1型糖尿病大鼠肾病的发展

获取原文

摘要

Gum Arabic (GA) is a branched-chain polysaccharide indigestible to humans and animals. It has been considered as a safe dietary fiber by the United States, Food and Drug Administration (FDA) since the last century. Diabetic nephropathy (DN) is a severe long-lasting complication of diabetes affecting up to 50% of diabetic patients. In the present study, we investigated the effect of GA on diabetic rat. A model of diabetic rat was established by intraperitoneal injection of Streptozotocin (STZ). The rats were divided into 3 groups: control group treated with a vehicle, diabetic group injected with STZ and diabetic rats group were given 10% of GA in drinking water for 30 days. Body weight, urinary glucose, protein, serum creatinine (Scr) and blood urinary nitrogen (BUN) concentrations were measured. E-cadherin, α-smooth muscle actin (α-SMA), Cytokeratin19, Vimentin and Transforming growth factor beta 1 (TGF-β1) mRNA expression were determined. GA was significantly (P<0.05) reduced body weight and spleen weight, serum urea, and urinary protein (P<0.05). In addition, GA significantly (P<0.01) decreased serum triglyceride, total cholesterol and HDL-c. Moreover, GA significantly (P<0.05) reduced α-SAM and TGF-β1 gene expression in kidney compared to STZ treated rats. In contrast, GA significantly (P<0.05) increased kidney cytokeratin19 and E-cadherin gene expression compared to the STZ group. A significant increase in tubulointerstitial collagen was shown in the STZ treated rats whereas it decreased for the GA treated group compared to the control group. The results indicate that GA may attenuate the development of nephropathy in type I diabetes rat.
机译:阿拉伯胶(Ga)是人类和动物难以消化的支链多糖。自上世纪以来,它被美国,食品和药物管理局(FDA)被视为安全的膳食纤维。糖尿病肾病(DN)是糖尿病的严重持久并发症,影响高达50%的糖尿病患者。在本研究中,我们研究了GA对糖尿病大鼠的影响。通过腹腔内注射链脲佐菌素(STZ)建立了一种糖尿病大鼠模型。将大鼠分为3组:用载体处理的对照组,注射STZ和糖尿病大鼠基团的糖尿病组给予饮用水10%GA饮用水30天。测量体重,尿葡萄糖,蛋白质,血清肌酐(SCR)和血尿氮(BUN)浓度。测定了E-CADHERIN,α-平滑肌肌动蛋白(α-SMA),细胞角酰胺19,VIMENIN和转化生长因子β1(TGF-β1)mRNA表达。 GA显着(P <0.05)减少体重和脾脏重量,血清尿素和尿蛋白(P <0.05)。此外,Ga显着(P <0.01)降低血清甘油三酯,总胆固醇和HDL-C.此外,与STZ处理的大鼠相比,GA显着(P <0.05)降低了肾脏中的α-SAM和TGF-β1基因表达。相比之下,与STZ组相比,Ga显着(P <0.05)增加肾细胞角蛋白酶19和E-Cadherin基因表达。在STZ处理的大鼠中显示了微管间胶原蛋白的显着增加,而与对照组相比,Ga治疗组降低。结果表明,GA可以衰减I型糖尿病大鼠肾病的发育。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号